India · Delayed Price · Currency is INR Mangalam Drugs & Organics Statistics
Total Valuation
NSE:MANGALAM has a market cap or net worth of INR 1.11 billion. The enterprise value is 2.04 billion.
| Market Cap | 1.11B |
| Enterprise Value | 2.04B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 15.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +6.56% |
| Owned by Insiders (%) | 25.30% |
| Owned by Institutions (%) | n/a |
| Float | 6.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -20.94 |
| EV / Sales | 0.69 |
| EV / EBITDA | 8.03 |
| EV / EBIT | 34.45 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.78 |
| Debt / FCF | n/a |
| Interest Coverage | 0.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.52% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.21M |
| Profits Per Employee | -203,379 |
| Employee Count | 480 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:MANGALAM has paid 9.65 million in taxes.
| Income Tax | 9.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.92% in the last 52 weeks. The beta is -0.19, so NSE:MANGALAM's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -41.92% |
| 50-Day Moving Average | 75.43 |
| 200-Day Moving Average | 85.70 |
| Relative Strength Index (RSI) | 39.39 |
| Average Volume (20 Days) | 23,252 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MANGALAM had revenue of INR 2.98 billion and -97.62 million in losses. Loss per share was -6.17.
| Revenue | 2.98B |
| Gross Profit | 1.32B |
| Operating Income | 59.34M |
| Pretax Income | -87.97M |
| Net Income | -97.62M |
| EBITDA | 254.71M |
| EBIT | 59.34M |
| Loss Per Share | -6.17 |
Balance Sheet
The company has 25.89 million in cash and 962.30 million in debt, giving a net cash position of -936.41 million.
| Cash & Cash Equivalents | 25.89M |
| Total Debt | 962.30M |
| Net Cash | -936.41M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 100.32 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.17%, with operating and profit margins of 1.99% and -3.27%.
| Gross Margin | 44.17% |
| Operating Margin | 1.99% |
| Pretax Margin | -2.95% |
| Profit Margin | -3.27% |
| EBITDA Margin | 8.54% |
| EBIT Margin | 1.99% |
| FCF Margin | n/a |
Dividends & Yields
NSE:MANGALAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -8.81% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |